AU2003251875A1 - Combination therapy for the treatment of neoplasms - Google Patents
Combination therapy for the treatment of neoplasmsInfo
- Publication number
- AU2003251875A1 AU2003251875A1 AU2003251875A AU2003251875A AU2003251875A1 AU 2003251875 A1 AU2003251875 A1 AU 2003251875A1 AU 2003251875 A AU2003251875 A AU 2003251875A AU 2003251875 A AU2003251875 A AU 2003251875A AU 2003251875 A1 AU2003251875 A1 AU 2003251875A1
- Authority
- AU
- Australia
- Prior art keywords
- neoplasms
- treatment
- combination therapy
- therapy
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39612002P | 2002-07-15 | 2002-07-15 | |
US60/396,120 | 2002-07-15 | ||
US40090502P | 2002-08-02 | 2002-08-02 | |
US60/400,905 | 2002-08-02 | ||
PCT/US2003/021783 WO2004007676A2 (en) | 2002-07-15 | 2003-07-14 | Combination therapy for the treatment of neoplasms |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003251875A1 true AU2003251875A1 (en) | 2004-02-02 |
AU2003251875A8 AU2003251875A8 (en) | 2004-02-02 |
Family
ID=30118565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003251875A Abandoned AU2003251875A1 (en) | 2002-07-15 | 2003-07-14 | Combination therapy for the treatment of neoplasms |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003251875A1 (en) |
WO (1) | WO2004007676A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2456269A1 (en) * | 2001-08-23 | 2003-03-06 | The Government Of The United States Of America | Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives |
KR20060125810A (en) * | 2003-12-19 | 2006-12-06 | 노파르티스 아게 | Combination of (a) n-[5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2methylphenyl]-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof |
JP5401849B2 (en) * | 2008-06-30 | 2014-01-29 | 山陽色素株式会社 | Pigment dispersion for color filters |
WO2010048712A1 (en) * | 2008-10-31 | 2010-05-06 | University Health Network | Ciclopirox and cytarabine for the treatment of leukemic disorders |
CN104945318A (en) | 2010-06-01 | 2015-09-30 | 拜欧赛里克斯公司 | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases |
US20130178503A1 (en) * | 2010-06-01 | 2013-07-11 | Biotheryx Inc. | Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone |
IT1405078B1 (en) * | 2010-06-23 | 2013-12-16 | Quattrone | COMPOUNDS FOR THE TREATMENT OF TUMORS WHICH CARRY MYC DEREGOLATE ONCOPROTEINS |
TWI672141B (en) | 2014-02-20 | 2019-09-21 | 美商醫科泰生技 | Molecules for administration to ros1 mutant cancer cells |
CN107206012A (en) * | 2014-11-11 | 2017-09-26 | 堪萨斯大学 | The method that carcinoma of urinary bladder is treated with Ciclopirox, Ciclopirox Olamine or Ciclopirox prodrug |
JP6744309B2 (en) | 2014-12-02 | 2020-08-19 | イグニタ,インコーポレイテッド | Combination for the treatment of neuroblastoma |
MX2018007266A (en) | 2015-12-18 | 2018-11-09 | Ignyta Inc | Combinations for the treatment of cancer. |
AU2018302170B2 (en) | 2017-07-19 | 2024-02-29 | Ignyta, Inc. | Pharmaceutical compositions comprising entrectinib |
JP7311498B2 (en) | 2017-10-17 | 2023-07-19 | イグナイタ インコーポレイテッド | Pharmaceutical compositions and dosage forms |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2114569T3 (en) * | 1991-10-16 | 1998-06-01 | Richardson Vicks Inc | IMPROVED SKIN PENETRATION SYSTEM FOR THE IMPROVED TOPICAL ADMINISTRATION OF PHARMACES. |
EG20380A (en) * | 1991-10-16 | 1999-02-28 | Richardson Vicks Inc | Enhanced skin penetration system for improved topical delivery of drugs |
US5846984A (en) * | 1996-01-19 | 1998-12-08 | The Trustees Of Columbia University In The City Of New York | Use of ciclopirox or a pharmaceutically acceptable salt thereof for inhibiting neuronal cell damage or neuronal cell death |
-
2003
- 2003-07-14 AU AU2003251875A patent/AU2003251875A1/en not_active Abandoned
- 2003-07-14 WO PCT/US2003/021783 patent/WO2004007676A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004007676A2 (en) | 2004-01-22 |
WO2004007676A3 (en) | 2004-04-08 |
AU2003251875A8 (en) | 2004-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003249244A1 (en) | Methods for the treatment of neoplasms | |
IL164599A0 (en) | Combination therapy for the treatment of cancer | |
ZA200500618B (en) | Combinations of drugs for the treatment of neoplasms | |
PL375532A1 (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
EP1635813A4 (en) | Combination therapy for the treatment of dyslipidemia | |
GB0201850D0 (en) | Therapeutic treatment | |
GB0216321D0 (en) | Therapeutic treatment | |
AU2003224654A1 (en) | Photodynamic therapy for pre-melanomas | |
EP1534074A4 (en) | Combination therapy for the treatment of obesity | |
HK1072443A1 (en) | Immunoconjugates for the treatment of tumours | |
IL159887A0 (en) | Combination therapy for the treatment of cancer | |
HK1078784A1 (en) | Therapeutic treatment | |
AU2003212634A1 (en) | Compounds useful in the treatment of cancer | |
EP1651211A4 (en) | Combination of drugs for the treatment of neoplasms | |
GB0223367D0 (en) | Therapeutic treatment | |
AU2003251875A1 (en) | Combination therapy for the treatment of neoplasms | |
AU2003247005A1 (en) | Therapy combination | |
AU2003251904A1 (en) | Combinations of drugs for the treatment of neoplasms | |
AU2003245794A1 (en) | Glycosaminoglycan-dnase combination therapy | |
AU2003223538A1 (en) | Methods for the treatment of cancer | |
IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
GB0210464D0 (en) | Therapeutic treatment | |
AU2001285156A1 (en) | Combination therapy for the treatment of migraine | |
AU2003296545A1 (en) | Use of a trpm8-activating substance for the treatment of tumours |